SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-24-035858
Filing Date
2024-04-24
Accepted
2024-04-24 17:13:41
Documents
11

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0203961-f1_universe.htm F-1 581412
2 OPINION OF OGIER (CAYMAN) LLP REGARDING THE VALIDITY OF THE SECURITIES BEING REG ea020396101ex5-1_universe.htm EX-5.1 80435
3 FORM OF SUBSCRIPTION AGREEMENT ea020396101ex10-1_universe.htm EX-10.1 16679
4 CONSENT OF YCM CPA INC ea020396101ex23-2_universe.htm EX-23.2 2469
5 CONSENT OF ALLBRIGHT LAW OFFICES (FUZHOU) ea020396101ex23-3_universe.htm EX-23.3 5764
6 FILING FEE TABLE ea020396101ex-fee_universe.htm EX-FILING FEES 12431
7 GRAPHIC ex5-1_001.jpg GRAPHIC 1963
8 GRAPHIC image_001.jpg GRAPHIC 57592
9 GRAPHIC image_002.jpg GRAPHIC 30353
10 GRAPHIC ex23-2_001.jpg GRAPHIC 8425
11 GRAPHIC ex23-3_001.jpg GRAPHIC 14773
  Complete submission text file 0001213900-24-035858.txt   856790
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: F-1 | Act: 33 | File No.: 333-278914 | Film No.: 24871539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)